PDGM a real sleeper. Interesting stuff.
``Paradigm Genetics is a pioneer in the emerging science of metabolomics, and I am delighted to join them in their efforts,'' said Hood. ``I believe that metabolomics will prove to be a very valuable complement to traditional genomic technologies. It holds great promise in the field of systems biology, with the potential to accelerate and improve the analyses of drug targets, lead compounds and predictive medicine.''
Paradigm has developed a robust, integrated functional genomics and metabolomics platform, along with its proprietary informatics technologies, to deliver high value genomic information to the human health, agriculture and nutrition industries. The company has validated its technology in agriculture through its partnerships with Bayer and Monsanto and is now aggressively entering the field of human health with its proprietary metabolomics technology, MetaVantage(TM), created by Paradigm to address the needs of drug discovery and development companies. |